{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T04:05:53Z","timestamp":1795147553554,"version":"4.10.3"},"reference-count":63,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. bras. pneumol."],"published-print":{"date-parts":[[2010,10]]},"abstract":"<jats:p>Os objetivos principais do tratamento da tuberculose s\u00e3o curar o paciente e minimizar a possibilidade de transmiss\u00e3o do bacilo para indiv\u00edduos saud\u00e1veis. Rea\u00e7\u00f5es adversas ou intera\u00e7\u00f5es das drogas antituberculose entre si e com outros f\u00e1rmacos podem causar modifica\u00e7\u00e3o ou descontinua\u00e7\u00e3o da terap\u00eautica. Revisamos sucintamente o novo tratamento farmacol\u00f3gico da tuberculose introduzido pelo Minist\u00e9rio da Sa\u00fade do Brasil em 2009 e mostramos os mecanismos gerais de a\u00e7\u00e3o, absor\u00e7\u00e3o, metaboliza\u00e7\u00e3o e excre\u00e7\u00e3o dos medicamentos utilizados no esquema b\u00e1sico. Descrevemos as rea\u00e7\u00f5es adversas e as intera\u00e7\u00f5es (com medicamentos, alimentos e anti\u00e1cidos) assim como a abordagem mais adequada para situa\u00e7\u00f5es especiais, como gravidez, amamenta\u00e7\u00e3o, insufici\u00eancia hep\u00e1tica e renal. Tamb\u00e9m descrevemos os mecanismos pelos quais as intera\u00e7\u00f5es das drogas antituberculose do esquema b\u00e1sico podem causar hepatite medicamentosa e as poss\u00edveis alternativas nessa situa\u00e7\u00e3o.<\/jats:p>","DOI":"10.1590\/s1806-37132010000500016","type":"journal-article","created":{"date-parts":[[2010,11,12]],"date-time":"2010-11-12T21:18:27Z","timestamp":1289596707000},"page":"626-640","source":"Crossref","is-referenced-by-count":152,"title":["Drogas antituberculose: intera\u00e7\u00f5es medicamentosas, efeitos adversos e utiliza\u00e7\u00e3o em situa\u00e7\u00f5es especiais - parte 1: f\u00e1rmacos de primeira linha"],"prefix":"10.1590","volume":"36","author":[{"given":"Marcos Abdo","family":"Arbex","sequence":"first","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo; Secretaria de Estado da Sa\u00fade do Estado de S\u00e3o Paulo,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00edlia de Castro Lima","family":"Varella","sequence":"additional","affiliation":[{"name":"Universidade de Mogi das Cruzes,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lio Ribeiro de","family":"Siqueira","sequence":"additional","affiliation":[{"name":"Universidade do Estado do Rio de Janeiro,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Augusto Fi\u00faza de","family":"Mello","sequence":"additional","affiliation":[{"name":"Secretaria de Estado da Sa\u00fade do Estado de S\u00e3o Paulo,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","series-title":"Nota t\u00e9cnica sobre as mudan\u00e7as no tratamento da tuberculose no Brasil para adultos e adolescentes: vers\u00e3o 2","year":"2009"},{"issue":"10","key":"ref2","first-page":"1018","article-title":"III Brazilian Thoracic Association Guidelines on tuberculosis","volume":"35","author":"Conde MB","year":"2009","journal-title":"J Bras Pneumol"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: treatment of tuberculosis","volume":"167","author":"Blumberg HM","year":"2003","journal-title":"Am J Respir Crit Care Med","ISSN":"https:\/\/id.crossref.org\/issn\/1073-449X","issn-type":"print"},{"key":"ref4","series-title":"Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis: Emergency Update 2008","year":"2008"},{"key":"ref5","series-title":"Treatment of Tuberculosis: Guidelines for National Programmes","year":"2003"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.mcna.2006.06.008","article-title":"Antibiotic drug interactions","volume":"90","author":"Pai MP","year":"2006","journal-title":"Med Clin North Am","ISSN":"https:\/\/id.crossref.org\/issn\/0025-7125","issn-type":"print"},{"key":"ref7","series-title":"Controle da tuberculose: uma proposta de integra\u00e7\u00e3o ensino-servi\u00e7o","year":"2002"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1183\/09031936.96.09102026","article-title":"Risk factors for sideeffects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis","volume":"9","author":"Schaberg T","year":"1996","journal-title":"Eur Respir J","ISSN":"https:\/\/id.crossref.org\/issn\/0903-1936","issn-type":"print"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/pds.1468","article-title":"Adverse reactions of antituberculosis drugs in hospitalized patients: incidence, severity and risk factors","volume":"16","author":"Javadi MR","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1164\/rccm.200206-626OC","article-title":"Incidence of serious side effects from firstline antituberculosis drugs among patients treated for active tuberculosis","volume":"167","author":"Yee D","year":"2003","journal-title":"Am J Respir Crit Care Med","ISSN":"https:\/\/id.crossref.org\/issn\/1073-449X","issn-type":"print"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/thx.2006.058867","article-title":"Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection","volume":"61","author":"Breen RA","year":"2006","journal-title":"Thorax","ISSN":"https:\/\/id.crossref.org\/issn\/0040-6376","issn-type":"print"},{"issue":"12","key":"ref12","first-page":"1314","article-title":"Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia","volume":"11","author":"Shin SS","year":"2007","journal-title":"Int J Tuberc Lung Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1027-3719","issn-type":"print"},{"issue":"3","key":"ref13","first-page":"134","article-title":"Evaluation of anti-tuberculosis induced adverse reactions in hospitalized patients","volume":"4","author":"Gholami K","year":"2006","journal-title":"Pharm Pract"},{"issue":"12","key":"ref14","first-page":"1049","article-title":"Adverse effects of tuberculosis treatment: experience at an outpatient clinic of a teaching hospital in the city of S\u00e3o Paulo, Brazil","volume":"34","author":"Vieira DE","year":"2008","journal-title":"J Bras Pneumol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev.pharmtox.45.120403.100120","article-title":"The magic bullets and tuberculosis drug targets","volume":"45","author":"Zhang Y","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol","ISSN":"https:\/\/id.crossref.org\/issn\/0362-1642","issn-type":"print"},{"issue":"2","key":"ref16","first-page":"112","article-title":"Handbook of Anti-Tuberculosis Agents","volume":"88","year":"2008","journal-title":"Tuberculosis (Edinb)"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1286-4579(00)00359-2","article-title":"The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis","volume":"2","author":"Slayden RA","year":"2000","journal-title":"Microbes Infect"},{"issue":"196","key":"ref18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-3-642-00663-0_7","article-title":"Role of reactive metabolites in drug-induced hepatotoxicity","author":"Srivastava A","year":"2010","journal-title":"Handb Exp Pharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0171-2004","issn-type":"print"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/MJT.0b013e31818f9eae","article-title":"Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis cases","volume":"17","author":"Baghaei P","year":"2010","journal-title":"Am J Ther","ISSN":"https:\/\/id.crossref.org\/issn\/1075-2765","issn-type":"print"},{"issue":"9","key":"ref20","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/j.1365-2036.2008.03822.x","article-title":"Review article: The use of potentially hepatotoxic drugs in patients with liver disease","volume":"28","author":"Gupta NK","year":"2008","journal-title":"Aliment Pharmacol Ther","ISSN":"https:\/\/id.crossref.org\/issn\/0269-2813","issn-type":"print"},{"issue":"9","key":"ref21","first-page":"1054","article-title":"The role of chronic hepatitis in isoniazid hepatotoxicity during treatment for latent tuberculosis infection","volume":"13","author":"Bliven EE","year":"2009","journal-title":"Int J Tuberc Lung Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1027-3719","issn-type":"print"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1164\/ajrccm\/140.3.700","article-title":"Twenty isoniazidassociated deaths in one state","volume":"140","author":"Moulding TS","year":"1989","journal-title":"Am Rev Respir Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0003-0805","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1590\/S1806-37132004000700003","article-title":"Tuberculose: Guia de vigil\u00e2ncia epidemiol\u00f3gica","volume":"30","author":"Silva Jr JB","year":"2004","journal-title":"J Bras Pneumol"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jinf.2009.06.011","article-title":"British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children","volume":"59","author":"Thwaites G","year":"2009","journal-title":"J Infect","ISSN":"https:\/\/id.crossref.org\/issn\/0163-4453","issn-type":"print"},{"issue":"3","key":"ref25","first-page":"205","article-title":"INH induced status epilepticus: response to pyridoxine","volume":"48","author":"Tajender V","year":"2006","journal-title":"Indian J Chest Dis Allied Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0377-9343","issn-type":"print"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s12325-008-0098-7","article-title":"Coma caused by isoniazid poisoning in a patient treated with pyridoxine and hemodialysis","volume":"25","author":"Tai WP","year":"2008","journal-title":"Adv Ther","ISSN":"https:\/\/id.crossref.org\/issn\/0741-238X","issn-type":"print"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1517\/14740338.5.2.231","article-title":"Adverse reactions to firstline antituberculosis drugs","volume":"5","author":"Forget EJ","year":"2006","journal-title":"Expert Opin Drug Saf"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/thx.45.5.419","article-title":"Exacerbation of isoniazid induced peripheral neuropathy by pyridoxine","volume":"45","author":"Nisar M","year":"1990","journal-title":"Thorax","ISSN":"https:\/\/id.crossref.org\/issn\/0040-6376","issn-type":"print"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00403-008-0895-5","article-title":"Drug-induced lupus erythematosus","volume":"301","author":"Vedove CD","year":"2009","journal-title":"Arch Dermatol Res","ISSN":"https:\/\/id.crossref.org\/issn\/0340-3696","issn-type":"print"},{"issue":"6","key":"ref30","first-page":"361","article-title":"Severe systemic lupus erythematosus induced by isoniazid","volume":"65","author":"Rakotoson JL","year":"2009","journal-title":"Rev Pneumol Clin","ISSN":"https:\/\/id.crossref.org\/issn\/0761-8417","issn-type":"print"},{"issue":"1","key":"ref31","first-page":"8","article-title":"Risks of antibacterial agents in pregnancy","volume":"10","author":"Nardiello S","year":"2002","journal-title":"Infez Med"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1542\/peds.108.3.776","article-title":"American Academy of Pediatrics Committee on Drugs: Transfer of drugs and other chemicals into human milk","volume":"108","year":"2001","journal-title":"Pediatrics","ISSN":"https:\/\/id.crossref.org\/issn\/0031-4005","issn-type":"print"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0929-6646(09)60040-1","article-title":"A prospective study of hepatitis during antituberculous treatment in Taiwanese patients and a review of the literature","volume":"108","author":"Sun HY","year":"2009","journal-title":"J Formos Med Assoc","ISSN":"https:\/\/id.crossref.org\/issn\/0929-6646","issn-type":"print"},{"issue":"3-4","key":"ref34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1399-3062.2005.00103.x","article-title":"Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy","volume":"7","author":"Vikrant S","year":"2005","journal-title":"Transpl Infect Dis"},{"key":"ref35","series-title":"Gu\u00eda de la Tuberculosis para M\u00e9dicos Especialistas","author":"Caminero Luna JA","year":"2003"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/AAC.45.2.382-392.2001","article-title":"Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A","volume":"45","author":"Desta Z","year":"2001","journal-title":"Antimicrob Agents Chemother","ISSN":"https:\/\/id.crossref.org\/issn\/0066-4804","issn-type":"print"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ejim.2004.07.005","article-title":"Isoniazid-induced hyperacute liver failure in a young patient receiving carbamazepine","volume":"15","author":"Campos-Franco J","year":"2004","journal-title":"Eur J Intern Med"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0002-9629(15)40533-6","article-title":"Isoniazid drug and food interactions","volume":"317","author":"Self TH","year":"1999","journal-title":"Am J Med Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9629","issn-type":"print"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1054\/tuld.1998.0002","article-title":"Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update","volume":"79","author":"Ramaswamy S","year":"1998","journal-title":"Tuber Lung Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0962-8479","issn-type":"print"},{"key":"ref40","series-title":"Goodman & Gilman: As Bases Farmacol\u00f3gicas da Terap\u00eautica","first-page":"1083","volume-title":"Quimioterapia da tuberculose, complexo Mycobacterium avium e hansen\u00edase","author":"Petri Jr WA","year":"2006"},{"key":"ref41","series-title":"Mandell, Douglas, and Bennett's principles and practice of infectious diseases","first-page":"533","volume-title":"Antimycobacterial agents","author":"Wallace, Jr RC","year":"2009"},{"issue":"4","key":"ref42","first-page":"447","article-title":"Haemorrhage associated with vitamin K deficiency in pregnant women and newborns: Relationship with rifampicin therapy in two cases","volume":"37","author":"Chouraqui JP","year":"1982","journal-title":"Therapie","ISSN":"https:\/\/id.crossref.org\/issn\/0040-5957","issn-type":"print"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/MAJ.0b013e31814a586a","article-title":"Update on rifampin and rifabutin drug interactions","volume":"335","author":"Baciewicz AM","year":"2008","journal-title":"Am J Med Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9629","issn-type":"print"},{"issue":"9","key":"ref44","doi-asserted-by":"crossref","first-page":"819 50","DOI":"10.2165\/00003088-200342090-00003","article-title":"Pharmacokinetic interactions with rifampicin: clinical relevance","volume":"42","author":"Niemi M","year":"2003","journal-title":"Clin Pharmacokinet","ISSN":"https:\/\/id.crossref.org\/issn\/0312-5963","issn-type":"print"},{"issue":"12","key":"ref45","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S1473-3099(09)70282-8","article-title":"Tuberculosis and diabetes mellitus: convergence of two epidemics","volume":"9","author":"Dooley KE","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1517\/17425250903393752","article-title":"Dose adjustment of the non-nucleoside reverse transcriptase inhibitors during concurrent rifampicin-containing tuberculosis therapy: one size does not fit all","volume":"6","author":"Kwara A","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00002018-200225020-00005","article-title":"Clinically significant interactions with drugs used in the treatment of tuberculosis","volume":"25","author":"Yew WW","year":"2002","journal-title":"Drug Saf","ISSN":"https:\/\/id.crossref.org\/issn\/0114-5916","issn-type":"print"},{"issue":"26","key":"ref48","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJM198412273112606","article-title":"Interaction of ketoconazole with rifampin and isoniazid","volume":"311","author":"Engelhard D","year":"1984","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"7","key":"ref49","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/thx.53.7.536","article-title":"Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society","volume":"53","year":"1998","journal-title":"Thorax","ISSN":"https:\/\/id.crossref.org\/issn\/0040-6376","issn-type":"print"},{"issue":"11","key":"ref50","first-page":"1320","article-title":"Mechanisms of drug resistance in Mycobacterium tuberculosis","volume":"13","author":"Zhang Y","year":"2009","journal-title":"Int J Tuberc Lung Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1027-3719","issn-type":"print"},{"key":"ref51","series-title":"The Treatment of Tuberculosis Guidelines","year":"2010"},{"issue":"3","key":"ref52","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/rr54","article-title":"The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis","volume":"2","author":"Somoskovi A","year":"2001","journal-title":"Respir Res"},{"issue":"2","key":"ref53","first-page":"141","article-title":"Handbook of Anti-Tuberculosis Agents","volume":"88","year":"2008","journal-title":"Tuberculosis"},{"issue":"2","key":"ref54","first-page":"102","article-title":"Handbook of Anti-Tuberculosis Agents","volume":"88","year":"2008","journal-title":"Tuberculosis"},{"issue":"10","key":"ref55","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/thx.41.10.737","article-title":"Ocular toxicity from ethambutol","volume":"41","author":"Citron KM","year":"1986","journal-title":"Thorax","ISSN":"https:\/\/id.crossref.org\/issn\/0040-6376","issn-type":"print"},{"issue":"1","key":"ref56","first-page":"56","article-title":"Ocular toxicity of ethambutol","volume":"12","author":"Chan RY","year":"2006","journal-title":"Hong Kong Med J"},{"issue":"5","key":"ref57","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1164\/ajrccm.159.5.9810034","article-title":"The effect of hemodialysis on isoniazid, rifampin, pyrazinamide, and ethambutol","volume":"159","author":"Malone RS","year":"1999","journal-title":"Am J Respir Crit Care Med","ISSN":"https:\/\/id.crossref.org\/issn\/1073-449X","issn-type":"print"},{"issue":"4","key":"ref58","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ccm.2009.08.015","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis in the West: Europe and United States: epidemiology, surveillance, and control","volume":"30","author":"Migliori GB","year":"2009","journal-title":"Clin Chest Med","ISSN":"https:\/\/id.crossref.org\/issn\/0272-5231","issn-type":"print"},{"issue":"8","key":"ref59","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ATS statement: hepatotoxicity of antituberculosis therapy","volume":"174","author":"Saukkonen JJ","year":"2006","journal-title":"Am J Respir Crit Care Med","ISSN":"https:\/\/id.crossref.org\/issn\/1073-449X","issn-type":"print"},{"issue":"6","key":"ref60","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1440-1843.2006.00941.x","article-title":"Antituberculosis drugs and hepatotoxicity","volume":"11","author":"Yew WW","year":"2006","journal-title":"Respirology","ISSN":"https:\/\/id.crossref.org\/issn\/1323-7799","issn-type":"print"},{"issue":"5","key":"ref61","first-page":"534","article-title":"Severe hepatotoxicity due to anti-tuberculosis drugs in Spain","volume":"9","author":"Tost JR","year":"2005","journal-title":"Int J Tuberc Lung Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1027-3719","issn-type":"print"},{"issue":"2","key":"ref62","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1440-1746.2007.05207.x","article-title":"Antituberculosis druginduced hepatotoxicity: concise up-to-date review","volume":"23","author":"Tostmann A","year":"2008","journal-title":"J Gastroenterol Hepatol","ISSN":"https:\/\/id.crossref.org\/issn\/0815-9319","issn-type":"print"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1111\/j.1440-1843.2008.01340.x","article-title":"Treatment of tuberculosis in presence of hepatic and renal impairment","volume":"13","author":"Chang KS","year":"2008","journal-title":"Respirology","ISSN":"https:\/\/id.crossref.org\/issn\/1323-7799","issn-type":"print"}],"container-title":["Jornal Brasileiro de Pneumologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/jbpneu\/v36n5\/v36n5a16.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T13:35:36Z","timestamp":1495805736000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1806-37132010000500016&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S1806-37132010000500016"],"URL":"https:\/\/doi.org\/10.1590\/s1806-37132010000500016","relation":{},"ISSN":["1806-3713"],"issn-type":[{"value":"1806-3713","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}